1
|
TRIM5 suppresses cross-species transmission of a primate immunodeficiency virus and selects for emergence of resistant variants in the new species.
|
PLoS Biol
|
2010
|
3.21
|
2
|
Toward an AIDS vaccine: lessons from natural simian immunodeficiency virus infections of African nonhuman primate hosts.
|
Nat Med
|
2009
|
2.41
|
3
|
Paucity of CD4+CCR5+ T cells is a typical feature of natural SIV hosts.
|
Blood
|
2006
|
2.40
|
4
|
Balancing selection and the evolution of functional polymorphism in Old World monkey TRIM5alpha.
|
Proc Natl Acad Sci U S A
|
2006
|
2.16
|
5
|
Molecular epidemiology of simian immunodeficiency virus SIVsm in U.S. primate centers unravels the origin of SIVmac and SIVstm.
|
J Virol
|
2005
|
1.66
|
6
|
Differential CD4+ T-lymphocyte apoptosis and bystander T-cell activation in rhesus macaques and sooty mangabeys during acute simian immunodeficiency virus infection.
|
J Virol
|
2008
|
1.56
|
7
|
Short-lived infected cells support virus replication in sooty mangabeys naturally infected with simian immunodeficiency virus: implications for AIDS pathogenesis.
|
J Virol
|
2008
|
1.51
|
8
|
Th-1-type cytotoxic CD8+ T-lymphocyte responses to simian immunodeficiency virus (SIV) are a consistent feature of natural SIV infection in sooty mangabeys.
|
J Virol
|
2006
|
1.44
|
9
|
Experimental rhesus lymphocryptovirus infection in immunosuppressed macaques: an animal model for Epstein-Barr virus pathogenesis in the immunosuppressed host.
|
Blood
|
2004
|
1.32
|
10
|
Genomic sequence of rhesus cytomegalovirus 180.92: insights into the coding potential of rhesus cytomegalovirus.
|
J Virol
|
2006
|
1.31
|
11
|
Flow cytometric detection of degranulation reveals phenotypic heterogeneity of degranulating CMV-specific CD8+ T lymphocytes in rhesus macaques.
|
J Immunol Methods
|
2007
|
1.14
|
12
|
Kuru experiments triggered the emergence of pathogenic SIVmac.
|
AIDS
|
2006
|
1.11
|
13
|
Optimization of intracellular cytokine staining for the quantitation of antigen-specific CD4+ T cell responses in rhesus macaques.
|
J Immunol Methods
|
2004
|
1.08
|
14
|
Immunogenicity and protective efficacy of DNA vaccines expressing rhesus cytomegalovirus glycoprotein B, phosphoprotein 65-2, and viral interleukin-10 in rhesus macaques.
|
J Virol
|
2006
|
1.06
|
15
|
Activation of cytomegalovirus in pig-to-primate organ xenotransplantation.
|
J Virol
|
2002
|
1.03
|
16
|
Cross-reactive recognition of human and primate cytomegalovirus sequences by human CD4 cytotoxic T lymphocytes specific for glycoprotein B and H.
|
Eur J Immunol
|
2004
|
1.02
|
17
|
Limited ability of humoral immune responses in control of viremia during infection with SIVsmmD215 strain.
|
Blood
|
2009
|
1.00
|
18
|
Inhibition of adaptive immune responses leads to a fatal clinical outcome in SIV-infected pigtailed macaques but not vervet African green monkeys.
|
PLoS Pathog
|
2009
|
0.98
|
19
|
Alpha E beta 7 (CD103) expression identifies a highly active, tonsil-resident effector-memory CTL population.
|
J Immunol
|
2005
|
0.96
|
20
|
The BZLF1 homolog of an Epstein-Barr-related gamma-herpesvirus is a frequent target of the CTL response in persistently infected rhesus macaques.
|
J Immunol
|
2006
|
0.96
|
21
|
Selective downregulation of rhesus macaque and sooty mangabey major histocompatibility complex class I molecules by Nef alleles of simian immunodeficiency virus and human immunodeficiency virus type 2.
|
J Virol
|
2008
|
0.96
|
22
|
Expression of CD8alpha identifies a distinct subset of effector memory CD4+ T lymphocytes.
|
Immunology
|
2006
|
0.96
|
23
|
The CD8+ T-cell response to an Epstein-Barr virus-related gammaherpesvirus infecting rhesus macaques provides evidence for immune evasion by the EBNA-1 homologue.
|
J Virol
|
2005
|
0.95
|
24
|
Suppression of adaptive immune responses during primary SIV infection of sabaeus African green monkeys delays partial containment of viremia but does not induce disease.
|
Blood
|
2010
|
0.94
|
25
|
Early induction of polyfunctional simian immunodeficiency virus (SIV)-specific T lymphocytes and rapid disappearance of SIV from lymph nodes of sooty mangabeys during primary infection.
|
J Immunol
|
2011
|
0.93
|
26
|
Quantification of the relative importance of CTL, B cell, NK cell, and target cell limitation in the control of primary SIV-infection.
|
PLoS Comput Biol
|
2011
|
0.92
|
27
|
HIV: viral blitzkrieg.
|
Nature
|
2005
|
0.92
|
28
|
Characterization and immunological analysis of the rhesus cytomegalovirus homologue (Rh112) of the human cytomegalovirus UL83 lower matrix phosphoprotein (pp65).
|
J Gen Virol
|
2006
|
0.91
|
29
|
Isolation of viable antigen-specific CD4 T cells by CD40L surface trapping.
|
J Immunol Methods
|
2005
|
0.89
|
30
|
Loss of effector and anti-inflammatory natural killer T lymphocyte function in pathogenic simian immunodeficiency virus infection.
|
PLoS Pathog
|
2012
|
0.86
|
31
|
Reduced efficacy of ganciclovir against porcine and baboon cytomegalovirus in pig-to-baboon xenotransplantation.
|
Am J Transplant
|
2003
|
0.85
|
32
|
Patterns of acute rhesus cytomegalovirus (RhCMV) infection predict long-term RhCMV infection.
|
J Virol
|
2012
|
0.85
|
33
|
Heterogeneity in phenotype and function of CD8+ and CD4/CD8 double-negative Natural Killer T cell subsets in sooty mangabeys.
|
J Med Primatol
|
2010
|
0.84
|
34
|
Paucity of CD4+ natural killer T (NKT) lymphocytes in sooty mangabeys is associated with lack of NKT cell depletion after SIV infection.
|
PLoS One
|
2010
|
0.84
|
35
|
Novel MHC class I full-length allele and haplotype characterization in sooty mangabeys.
|
Immunogenetics
|
2015
|
0.79
|
36
|
Acute SIV infection in sooty mangabey monkeys is characterized by rapid virus clearance from lymph nodes and absence of productive infection in germinal centers.
|
PLoS One
|
2013
|
0.78
|
37
|
Kinetics of T lymphocyte apoptosis and the cellular immune response in SIVmac239-infected rhesus macaques.
|
J Med Primatol
|
2008
|
0.78
|
38
|
Characterization of MHC class I alleles in sooty mangabeys as a tool for evaluating cellular immunity in natural hosts of SIV infection.
|
Immunogenetics
|
2015
|
0.77
|
39
|
A summary of meeting proceedings for 'Measuring immune responses in non-human primates for drug development-opportunities and challenges for predicting human efficacy and immunotoxicity'.
|
J Immunotoxicol
|
2012
|
0.75
|